Biotechs Clash Over Cancer Drug Discovery In Chancery
AnaptysBio and Tesaro, alongside Tesaro parent GlaxoSmithKline LLC, sparred Friday in the Delaware Chancery Court over the scope of discovery in the biotechnology firms' contract fight regarding cancer drug Jemperli, with...To view the full article, register now.
Already a subscriber? Click here to view full article